Inflammation biomarkers in sputum for clinical trials in cystic fibrosis: current understanding and gaps in knowledge-Reference-Cited by-同舟云学术

Inflammation biomarkers in sputum for clinical trials in cystic fibrosis: current understanding and gaps in knowledge

Published:2021-11 Issue: Volume: Page:
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Lepissier Agathe,Addy Charlotte,Hayes Kate,Noel Sabrina,Bui Stéphanie,Burgel Pierre-Régis,Dupont Lieven,Eickmeier Olaf,Fayon Michael,Leal Teresinha,Lopes Carlos,Downey Damian G.,Sermet-Gaudelus Isabelle

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference143 articles.

1. Improvements in symptomatic treatment strategies for cystic fibrosis: delivering CF care in the 21st century;Addy;Expert Opin Orph Drugs,2015

2. Origins of cystic fibrosis lung disease;Stoltz;N Engl J Med,2015

3. Risk factors for bronchiectasis in children with cystic fibrosis;Sly;N Engl J Med,2013

4. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications;Cohen-Cymberknoh;Thorax,2013

5. Infection is not required for muco-inflammatory Lung Disease in CFTR-Knockout Ferrets;Rosen;Am J Respir Crit Care Med,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sputum Proteomics reveals unique signatures linked to key outcomes in cystic fibrosis trials;2024-07-23

2. Detection of cytokines in nasal lavage samples of patients with cystic fibrosis: comparison of two different cytokine detection assays;BMC Pulmonary Medicine;2024-06-19

3. Anti-inflammatory effects of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis heterozygous for F508del;PLOS ONE;2024-05-31

4. Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases;International Journal of Molecular Sciences;2024-02-05

5. Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis;Journal of Personalized Medicine;2024-01-13